19

Nov

2020

17:00

GMT

Webinar

Controversies Regarding Subclinical Leaflet Thrombosis After TAVR

Average (ratings)
No ratings
Your rating

Overview

A substantial number of patients develops a subclinical leaflet thrombosis (SLT) after transcatheter aortic valve replacement (TAVR).

The thrombus forms on the leaflets, which can lead to valve dysfunction and possibly to early valve degeneration. Multidetector computed tomography is the most sensitive imaging technique at detecting SLT.

Patients on antiplatelet drugs are at higher risk to develop SLT as compared to those on anticoagulant. During the live debate, the experts in the field will discuss controversies concerning SLT, including the routine use of oral anticoagulants and CT exams after TAVR.

Faculty:


Mamas A Mamas

Mamas A Mamas


Kimberly Atianzar

Kimberly Atianzar


Poonam Velagapudi

Poonam Velagapudi


Renate B Schnabel

Renate B Schnabel


Jolanta Siller-Matula

Jolanta Siller-Matula

Agenda

Program

Lecture: Subclinical leaflet thrombosis after TAVR: Numbers and facts Jolanta Siller-Matula

Patients should receive routine CT screening after TAVR to exclude subclinical valve thrombosis

Debate 1: Introduction Jolanta Siller-Matula
Debate 1: PRO Mamas Mamas
Debate 1: CONTRA Poonam Velagapudi
Debate 1: Panel discussion Panel

Patients should be routinely discharged on oral anticoagulants for prevention of subclinical valve thrombosis after TAVR

Introduction Jolanta Siller-Matula
Debate 2: PRO Kimberly Atianzar
Debate 2: CONTRA Renate Schnabel
Debate 2: Panel discussion Panel

Learning Objectives

  • To learn about the natural history, incidence and clinical implications of SLT
  • To learn about the mechanisms that may lead to SLT
  • To understand the diagnostic criteria SLT
  • To discuss the prevention and treatment options for SLT

Audience

  • Interventional cardiologists with focus on TAVR procedures
  • Cardiac Imaging specialists (Echocardiography, Computer Tomography)
  • General cardiologists
  • Specialists interested in management of antithrombotic therapies after TAVR

Faculty Biographies


Mamas A Mamas

Mamas A Mamas

Professor Mamas Mamas trained in Medicine at the University of Oxford, completing his clinical training in 2000. He is a Professor of Cardiology at Keele University and is a practising interventional cardiologist.

View full profile

Kimberly Atianzar

Kimberly Atianzar

Kimberly Atianzar, MD, is a Director, Structural Heart Program Director, Structural Imaging Assistant Professor of Medicine Medical College of Georgia at Augusta University, Augusta, GA Editor for the Fellows and Early Career Structuralists Forum for Structural Heart: Journal of the Heart Team.

View full profile

Poonam Velagapudi

Poonam Velagapudi

Dr Poonam Velagapudi is a Structural Interventional Cardiologist, Assistant Professor of Medicine and Associate Program Director for Cardiovascular Medicine fellowship at the University of Nebraska.

View full profile

Renate B Schnabel

Renate B Schnabel

Renate Schnabel is a consultant in cardiology at University Heart Centre Hamburg, Germany. She graduated from medical school in Mainz, Germany in 2002. After a research fellowship at the Framingham Heart Study, Boston University, she moved to Hamburg.

View full profile

Jolanta Siller-Matula

Jolanta Siller-Matula

Dr Jolanta Siller-Matula is an Associate Professor in the Department of Cardiology at the Medical University of Vienna, Austria. She is an interventional cardiologist specialising in coronary and structural cardiac interventions.

View full profile